• 1
    Zur Hausen H. Papillomavirus infections — a major cause of human cancers. Biochim Biphys Acta. 1996; 1288: 5578.
  • 2
    Joste NE, Rushing L, Granados R, et al. Bethesda classification of cervicovaginal smears: reproducibility and viral correlates. Hum Pathol. 1996; 27: 581585.
  • 3
    Kaufman RH, Adam E, Icenogle J et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol. 1997; 176: 8792.
  • 4
    Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 1219.
  • 5
    Zielinsky GD, Snijders PJ, Rozendaal L, et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer. 2001; 85: 398404.
  • 6
    Hanselaar AG, Vooijs GP, Mayall BH, Pahlplatz MM, Van't Hof-Grootenboer AE. DNA changes in progressive cervical intraepithelial neoplasia. Anal Cell Pathol. 1992; 4: 315324.
  • 7
    The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Acta Cytol. 1989; 33: 567572.
  • 8
    Lombard I, Vincent-Salomon A, Validire P, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol. 1998; 16: 26132619.
  • 9
    Lorincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am. 1996; 23: 707730.
  • 10
    Böcking A, Chatelain R. Diagnostic and prognostic value of DNA cytometry in gynaecologic cytology. Anal Quant Cytol Histol. 1989; 11: 177186.
  • 11
    Lorenzato M, Clavel C, Masure M, et al. DNA image cytometry and human papillomavirus (HPV) detection help to select smears at high risk of high grade cervical lesions. J Pathol. 2001; 194: 171176.
  • 12
    Bollmann R, Bollmann M, Henson DE, Bodo M. DNA cytometry confirms the utility of the Bethesda System for the classification of Papanicolaou smears. Cancer (Cancer Cytopathol). 2001; 93: 222228.
  • 13
    Haroske G, Baak JPA, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol. 2001; 23: 8995.
  • 14
    Feoli-Fonseca JC, Oligny LL, Filion M, et al. A two tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Diagn Mol Pathol. 1998; 7: 317323.
  • 15
    Jacobs MV, Snijders PJ, van den Brule JC, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997; 35: 791795.
  • 16
    Bauer HM, Greer CE, Manos MM. Determination of genital HPV infection using consensus PCR. In: HerringtonCS, McGeeJO. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press, 1992: 3342.
  • 17
    Crum CP, Mitao M, Levine RU, Silverstein S. Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol. 1985; 54: 675681.
  • 18
    Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999; 281: 16051610.
  • 19
    Cullen AP, Reid R, Campion M, Loricz AT. Analysis of the physical state of the different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J Virol. 1991; 65: 606612.
  • 20
    Nuovo GJ, Plaia TV, Belinsky SA, Baylin SB, Herman JG. In situ detection of hypermethylation induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA. 1999; 96: 1275412759.
  • 21
    Rader JS, Kamarasova T, Hüttner PC, Li L, Li Y, Gerhard DS. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene. 1996; 13: 27372741.
  • 22
    Heselmayer K, Schröck E, Manoir S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA. 1996; 93: 479484.
  • 23
    Rihet S, Lorenzato M, Clavel C. Oncogenic human papillomaviruses and ploidy in cervical lesions. J Clin Pathol. 1996; 49: 892896.
  • 24
    Winkler B, Crum CP, Fujii T, et al. Koilicytic lesions of the cervix: the relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content. Cancer. 1984; 53: 10811087.
  • 25
    Melsheimer P, Klaes R, Knebel-Doeberitz M, Bastert G. Prospective clinical study comparing DNA flow cytometry and HPV typing as predictive tests for persistence and progression of CIN I/II. Cytometry. 2001; 46: 166171.